Alopecia areata
RecruitingA study to evaluate the effectiveness and safety of LAD603 in adults with severe to very severe alopecia areata
- Disease:Alopecia areata
- Substances:–
Bulgaria- Participants:18–64 years
- Sponsor:Almirall S.A.
Rare diseases
Investigational molecules
Locations
Back to Bulgaria60 clinical trials in Lovech, Bulgaria. Every trial is listed in the EU Clinical Trials Register and updated daily.
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
BulgariaThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on respiratory viral infections and chronic conditions, including studies of RSV, hMPV, and influenza vaccines for older adults.
Multiple trials investigating innovative treatments for both acute and chronic respiratory conditions.
Comprehensive studies examining treatments for various inflammatory skin disorders, from chronic urticaria to severe psoriasis.
Advanced therapeutic approaches targeting specific dermatological pathways.
Innovative research in psychiatric disorders and heart conditions, exploring new treatment modalities.
Focus on both emergency interventions and long-term therapeutic solutions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.